Study of Exchange of Travoprost Intraocular Implant
Study sponsor: Glaukos Corporation
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2022-02-28Actual
Enrollment · participants33Actual
Source updated2023-09-26Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.